Order Article Reprints

Kim Y, Kim B, Wie SH, Kim J, Ki M, Cho YK, Lim SK, Lee JS, Kwon KT, Lee H, et al. Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative Escherichia coli Is ≤16 mg/L. Antibiotics. 2021; 10(1):37. https://doi.org/10.3390/antibiotics10010037

Kim, Yeonjae, Bongyoung Kim, Seong Heon Wie, Jieun Kim, Moran Ki, Yong Kyun Cho, Seung Kwan Lim, Jin Seo Lee, Ki Tae Kwon, Hyuck Lee, and et al. 2021. "Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative Escherichia coli Is ≤16 mg/L" Antibiotics 10, no. 1: 37. https://doi.org/10.3390/antibiotics10010037

Kim, Y., Kim, B., Wie, S. H., Kim, J., Ki, M., Cho, Y. K., Lim, S. K., Lee, J. S., Kwon, K. T., Lee, H., Cheong, H. J., Park, D. W., Ryu, S. Y., Chung, M. H., & Pai, H. (2021). Fluoroquinolone Can Be an Effective Treatment Option for Acute Pyelonephritis When the Minimum Inhibitory Concentration of Levofloxacin for the Causative Escherichia coli Is ≤16 mg/L. Antibiotics, 10(1), 37. https://doi.org/10.3390/antibiotics10010037